About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Afrin® WOWs Parents with Launch of Children’s Acute Medicated Nasal Sprays – Because One Sick Kid Can Throw Everything Off in An Instant

Children’s Afrin® products provide ridiculously FAST nasal congestion relief, so busy parents can get their families back on track. The WOW is REAL!

Afrin®, the #1 doctor and pharmacist recommended nasal spray brand1, announced today the launch of Children’s Afrin®, the children's acute medicated nasal spray that works fast and lasts up to 12 hours. Available in retail stores nationwide, the line of children’s medicated consumer products includes Afrin® Extra Moisturizing Stuffy Nose Spray and Afrin® No Drip Extra Moisturizing Stuffy Nose Spray.

Children’s Afrin® provides targeted fast relief, for children who suffer from nasal congestion due to colds or allergies. The children’s medicated product line offers nasal spray products for children two to six and six and up:

  • Afrin® Extra Moisturizing Stuffy Nose Pump Mist, for ages two to six years old, is specially formulated for young children and unblocks a stuffy nose fast
  • Afrin® No Drip Extra Moisturizing Stuffy Nose Pump Mist, for ages six years old and up, targets nasal congestion in seconds without dripping down the nose or throat

“There’s nothing worse than when you’re almost out the door, and your child runs over with their stuffy and snotty nose complaining of being sick because you know your plans for the day have been thwarted. That’s why we’re excited to bring the power of Afrin’s fast congestion relief to the whole family, so all ages can breathe more freely,” said Catherine Vennat, VP/GM, Upper Respiratory, Bayer Consumer Health U.S. “Children suffering from colds or allergies now have access to nasal congestion relief that works fast and allows children to feel like themselves again, and their busy parents to get their families back on track while juggling multiple responsibilities.”

The nasal sprays offer fast relief to children for up to 12 hours, providing comfort to children and their parents, all day or all night. Children’s Afrin® Medicated Nasal Sprays are available at mass retail locations. For more information, please visit https://www.afrin.com/ or follow us on Instagram and Twitter.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

1 Pharmacy Times Survey 2020

Contacts

Danielle Goonan

Senior Director, Strategic Communications, Brand PR, Influencer & Social, Bayer Consumer Health U.S.

danielle.goonan@bayer.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.